CTTH Insider Trading Activity and SEC Form 4 Filings
CTTH insider trading summary
Over the past 12 months, insiders at Ctt Pharmaceutical Holdings, Inc. (CTTH) reported 19 open-market purchases worth $16K by 1 insider and no sales on SEC Form 4. Net insider buying was $16K.
Latest CTTH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $450 (9,000 @ $0.05) |
| Oct 26, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $335 (5,880 @ $0.06) |
| Oct 15, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $114 (2,000 @ $0.06) |
| Oct 6, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $204 (3,700 @ $0.06) |
| Sep 28, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $187 (3,400 @ $0.06) |
| Sep 22, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $455 (10,100 @ $0.04) |
| Sep 22, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $455 (10,100 @ $0.04) |
| Sep 16, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $523 (10,900 @ $0.05) |
| Sep 4, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $479 (9,800 @ $0.05) |
| Sep 2, 2026 | Ctt Pharmaceutical Holdings, Inc. | CEO | Buy | $147 (3,000 @ $0.05) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.